multilayer tablet exclusion criteria from PK analysis due to emesis [Regulatives / Guidelines]

posted by jag009  – NJ, 2016-01-30 00:02 (3446 d 00:49 ago) – Posting: # 15899
Views: 4,079

Hi Shuanghe,

But does it matter if it's IR/XR with a single API or IR with API A and XR with API B?
The emesis criteria should be based on the IR Tmax. Okay, unless there is an IR product out there which has a really long Tmax such that it's actually longer than the dosing interval of the modified release.

Thanks
John

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,679 registered users;
32 visitors (0 registered, 32 guests [including 7 identified bots]).
Forum time: 01:51 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5